Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03325946 · ClinicalTrials.gov registry record

The FBRI VTC Neuromotor Research Clinic

A clinical trial of Autism and Cerebral Palsy, sponsored by Virginia Polytechnic Institute and State University.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT03325946 is a study of Autism and Cerebral Palsy that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 500 participants, above the 179-participant average among 104 other Autism trials with a reported enrollment target (179% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03325946, a study of Autism and Cerebral Palsy, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy. ACQUIREc Therapy is an evidenced-based approach to pediatric constraint-induced movement therapy, which refers to a multi-component form of therapy that is focused on helping children who have asymmetric motor abilities between the two sides of the body. Historically, ACQUIREc Therapy has the unimpaired or less impaired upper extremity constrained (by a cast or a splint) while also receiving active therapy from a specially trained therapist who shapes new skills and functional activities with the child's more impaired upper extremity but who is also a licensed Occupational or Physical Therapist (OT/PT). Therapy dosages are high much higher than tradition OT or PT - often lasting many hours per day, up to 6 hours a day, 5 days a week, for 2-4 weeks. Investigators have developed further treatments based on the same principles of intensive services combined with behavior shaping for other areas of the body that are also affected by weakness (e.g., the leg and trunk) also, but which usually do not involve constraint. These have been more generally labeled ACQUIRE Therapy. All forms involve intensive, play-based therapy for children with asymmetric motor impairments of the arms and hands. The primary focus of treatment is to facilitate the acquisition of new motor skills in the child's weaker body parts through high levels of intensive therapy using scientifically-based behavioral guidelines. Therapy is also delivered in naturalistic environments. ACQUIREc Therapy as a treatment method has been tested in two randomized controlled trials, and a specific manual for its implementation has been developed. Dr. (s) Ramey and DeLuca previously founded a similar clinic, The Pediatric Neuro

Interventions

  • BEHAVIORAL ACQUIRE Therapy

Study Locations (1)

Virginia

  • Fralin Biomedical Research Institute - VTC - Roanoke

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2013-01-01
Est. Completion 2029-12-31

What the Registry Record Tells You About NCT03325946

The ClinicalTrials.gov registry entry for NCT03325946 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 179-participant average among 104 other Autism trials with a reported enrollment target (179% higher). The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which ACQUIRE Therapy is the first listed.

NCT03325946 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03325946 about?

NCT03325946 is a clinical study titled "The FBRI VTC Neuromotor Research Clinic". The FBRI VTC Neuromotor Research Clinic was established and opened in May of 2013 to provide intensive therapeutic services to individuals with motor impairment secondary to neuromotor disorders. It is direct by Dr. Stephanie DeLuca and based on the principles surrounding ACQUIREc Therapy. ACQUIREc...

What is the current status of trial NCT03325946?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2013-01-01. Estimated completion is 2029-12-31.

What conditions does trial NCT03325946 study?

This clinical trial studies the following conditions: Autism, Cerebral Palsy, Acquired Brain Injury, Microcephaly, Trauma, Brain.

What interventions are being tested in trial NCT03325946?

The interventions under investigation include: ACQUIRE Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT03325946?

This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03325946 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.